Lymphohistiocytosis, Hemophagocytic Recruiting Phase 3 Trials for Ruxolitinib (DB08877)

Also known as: Hemophagocytic Lymphohistiocytosis / Erythrophagia / Histiocytosis hematophagic / Histiocytosis haematophagic / Haemophagocytosis / Hemophagocytosis / Haemophagocytic lymphohistiocytosis / Familial hemophagocytic reticulosis

IndicationStatusPhase
DBCOND0001493 (Lymphohistiocytosis, Hemophagocytic)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04120090Ruxolitinib as a Salvage Therapy for Hemophagocytic LymphohistiocytosisTreatment